1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Cannabis Suisse Corp.

Cannabis Suisse Corp.

CSUI
Cannabis Suisse Corp.US flagOther OTC
0.01
USD
+0.00
- -
600,788.00Market Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.01
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
-0.01
-0.01
-0.01
-0.01
-0.03
- -
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
-0.01
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
-0.01
-0.02
-0.03
-0.03
-0.05
- -
-0.04
Tangible Book Value per Share
- -
- -
- -
- -
-0.01
-0.01
-0.01
-0.01
-0.03
- -
-0.03
Basic Weighted Avg Shares
- -
57
57
52
36
34
33
42
47
- -
71
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
-187.94
-252.63
-301.83
-144.73
-704.92
-2,022.59
-3,426.82
-856.46
-1,280.06
-1,280.06
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-187.94
-252.63
-301.83
-160.35
-808.05
-2,418.15
-3,515.47
-3,955.38
-2,027.3
-2,027.3
Working Capital
- -
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-1
-2
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-206.89
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Aug'25
Nov'25
May'25
ST Debt
- -
- -
- -
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
71
71
71
Market Capitalization
1
1
1

Working Capital

FRC

•

in mil. unless spec.
Aug'25
Nov'25
May'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
71.46%
33.89%
Free Cash Flow
- -
41.48%
-1.15%
Net Income, GAAP
- -
42.88%
-61.56%
Sales/Revenue/Turnover
- -
7.99%
-25%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.03
2025
-0.01
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Scott W. Mcalister
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
10 North Newnan Street Jacksonville FL United States of America 90201
IPO Date
May 10, 2019
CIK
0001680132
Website
cannabissuissecorp.com
Similar Companies
Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ)
AB Science S.A. (0Q77.L)
Indoco Remedies Limited (INDOCO.BO)
Kaken Pharmaceutical Co., Ltd. (KKPCF)
Sequent Scientific Limited (SEQUENT.NS)
Red White & Bloom Brands Inc. (RWBYF)
Business
Cannabis Suisse Corp. engages in the real estate business, leasing commercial office and industrial space; it subleases portions of its commercial buildings to third parties. Incorporated in Nevada in 2016 and headquartered at 10 North Newnan Street, Suite A, Jacksonville, Florida, the company operates primarily in the United States real estate services sector with a focus on property rental activities. Formerly known as Geant Corp., it changed its name to Cannabis Suisse Corp. in February 2019, marking a significant rebranding; recent financials show trailing twelve-month revenue of $15,000, earnings of $92,850, and a market capitalization of approximately $516,000 as of late 2025, with ongoing SEC filings including an amended 10-K/A in September 2025. The company maintains low gross margins at 1.92% and high net profit margins at 619.01%, reflecting its asset-light subleasing model; no major partnerships, acquisitions, funding rounds, or new product launches are reported in the last 1-2 years. Scott W. Mcalister serves as chief executive officer, chief financial officer, and director.